Losortan Potassium
Product Images NDC 21695-717

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 21695-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Losartan (2e1f1640 C6ff 456f 8bec Ec3251065f46 01)

Chemical structure of Losartan Potassium, showing molecular arrangement including a chlorinated pyrimidine ring, phenyl groups, and potassium ion.*

FDA Label Image

Structured Formula For Losartan (2e1f1640 C6ff 456f 8bec Ec3251065f46 02)

A line graph comparing the percentage of patients with the primary endpoint over 66 study months between two drugs: Atenolol (dashed line) and Losartan Potassium (solid line). The graph shows cumulative patient percentages on the y-axis and study months on the x-axis, including a note on adjusted risk reduction of 13% with p=0.021.*

FDA Label Image

Structured Formula For Losartan (2e1f1640 C6ff 456f 8bec Ec3251065f46 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over 66 study months between two treatments: Atenolol (dashed line) and Losartan Potassium (solid line). The graph indicates adjusted risk reduction for Losartan Potassium treatment.*

FDA Label Image

Structured Formula For Losartan (2e1f1640 C6ff 456f 8bec Ec3251065f46 04)

A comparative forest plot chart showing hazard ratios with 95% confidence intervals for primary composite and stroke (fatal/non-fatal) outcomes between Losartan-K and Atenolol. The chart includes subgroup analyses by age, gender, race, ischemic heart disease (ISH), diabetes, and history of cardiovascular disease (CVD), displaying event rates and hazard ratios indicating relative effectiveness between the two treatments.*

FDA Label Image

Losartan Potassium 100mg (2e1f1640 C6ff 456f 8bec Ec3251065f46 05)

Label for Losartan Potassium 100 mg tablets, #30 count. The label indicates that each tablet contains 100 mg of Losartan Potassium and is described as white to off-white, capsule-shaped, and film-coated with a debossed logo on one side. The product is manufactured by Cadila Healthcare Ltd., Ahmedabad, India and distributed by Physician Partner, Thousand Oaks, CA. The label includes storage instructions and emphasizes RX only status.*

FDA Label Image

Losartan Potassium 100mg (2e1f1640 C6ff 456f 8bec Ec3251065f46 06)

Losartan Potassium 100mg tablets label showing a quantity of 90 tablets. Distributed by Physician Partner, manufactured by Cadila Healthcare Ltd. The label includes product ID RL071790, lot number, and expiry date fields. It provides storage instructions and cautions to keep medication out of reach of children. The label also displays Physician Partner branding and website.*

FDA Label Image

Losartan Potassium 50mg (2e1f1640 C6ff 456f 8bec Ec3251065f46 07)

Losartan Potassium 50 mg tablets packaging label distributed by Physician Partner, a division of Rebel Distributors Corp. The label includes lot and expiration information, RX only status, and storage instructions. Tablets are white to off-white, capsule-shaped, film-coated, and debossed with the logo 'Z16'. Manufactured by Cadila Healthcare Ltd, Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.